Mark Dybul is the founder of Enochian BioSciences. Enochian BioSciences has raised $20M in total funding. Latest round: Seed.
Dr. Mark Dybul is the CEO of Enochian BioSciences, a biotechnology company focused on developing therapies for Hepatitis B Virus (HBV). He holds an MD and has previously served as a lead partner on deals involving biotechnology companies such as Renovaro Cube. His professional base is in Westport, Connecticut.
Full founder directory · Investor directory · Company funding database · Fundraising library